Wanting sex and getting an erection are different
PT-141 brought a small gain in desire for some women.
Sex may no longer interest you, even with someone you love. Some women felt a little better with this drug. Many felt sick as well. Your doctor needs to hear which sexual difficulty you have.
The short answer is a small gain for a limited group
Sex may lose its appeal while your feelings for a partner stay strong. Bremelanotide is the medicine researchers studied under the name PT-141. PT-141 affects desire through the brain and gained approval in June 2019 [6]. The benefit was small, and nausea, a sick feeling in the stomach, was common.
The approval concerns women before menopause, the time when monthly periods have ended for good. Their desire had faded after a time when sex interested them. Interest stayed low regardless of the partner, setting, or sexual activity. The loss upset them, and another illness or relationship problem couldn't explain it better.
Approval doesn't cover men, erection difficulties, or women who've reached menopause. A use beyond approval is called off-label; that term doesn't mean benefit is proved. At your visit, tell your doctor whether you still want sex but can't get an erection, or whether sex no longer appeals to you regardless of the partner or setting.
The largest PT-141 studies found small gains and frequent sickness
During the main PT-141 studies, desire improved slightly and its loss caused women less distress. Those results led to approval in June 2019 for certain women [6]. The approval left out male treatment and treatment after the permanent end of periods. Your sexual problem may have little in common with the difficulty studied.
The two RECONNECT studies included 1,267 women during Phase 3 [3]. This is the larger testing needed before a drug gains approval. Women improved a little more with medicine than with placebo, shots containing no drug [3]. The difference held up when researchers checked for chance, but desire improved only slightly.
Of those women, 684 joined a 52-week study with the medicine [4]. Not all stayed until the year ended. Desire remained better, and the researchers found no newly appearing safety problems. Without a placebo group, expectations of help could have affected the women's answers.
I'd ask your doctor whether a small improvement would matter to you if nausea made sex less pleasant, as some women quit because feeling sick outweighed the relief they felt. People trying laboratory products on themselves also describe stronger desire, unexpected erections, and sickness. Their accounts lack a comparison group, so you can't know which experiences the drug caused.
PT-141 peptide influences desire through your brain
The PT-141 peptide joins seven amino acids, small pieces used to make protein [1]. Proteins build body tissues and do many jobs inside cells. This laboratory-made drug joins those pieces into a ring, which resists breakdown. A sturdy drug doesn't guarantee worthwhile relief from lost desire.
The drug resembles a hormone, which carries messages around the body. The natural hormone influences sexual interest and skin color. PT-141 produces some of the same responses by acting on brain and skin cells. Your body still breaks down and removes the drug.
The melanocortin 4 receptor is a protein that receives messages affecting desire [1]. PT-141 activates this protein in brain cells and activates a related protein less strongly. Dopamine, a chemical that passes messages between brain cells, may help increase sexual interest [1]. The drug's action in skin cells can also deepen skin color.
Erection pills loosen muscle around blood vessels, allowing the penis to receive more blood. PT-141 doesn't produce that same action, and stronger desire needn't bring easier erections. The PT-141 brain studies include animal tests and scans in women. Those findings can't tell you whether your own erection problem would improve.
Laboratory PT-141 bottles don't meet prescription medicine checks
Bremelanotide has an FDA-approved prescription form; a clinician can also prescribe a compounded PT-141 preparation, which has no FDA approval. Research-labelled PT-141 remains for laboratory work and does not share the approved medicine's regulatory review [11]. That leaves you uncertain about strength, unwanted substances, and whether the named drug is present. The label alone can't answer those questions.
PT-141 doesn't increase testosterone, the hormone that supports male sexual function [12]. Nor does the drug help by widening blood vessels to the penis [1]. Explain to your doctor whether desire, erections, or both have become difficult. A result in women won't answer every question about a man's health.
The PT-141 results in women explain the benefit the studies actually found. The PT-141 unwanted effects describe why some women stopped using the drug. The PT-141 timing findings concern blood levels, which don't decide your treatment. Bring a study or medicine instruction if you want help checking a claim.
Some women stopped because nausea outweighed their relief
Feeling sick led some women to give up treatment. A small gain in desire wasn't enough to make continuing worthwhile. Read the PT-141 benefits and troubles before your next visit.